ZD6474, a Small Molecule Tyrosine Kinase Inhibitor, Potentiates the Anti-Tumor and Anti-Metastasis Effects of Radiation for Human Nasopharyngeal Carcinoma

By  

Current Cancer Drug Targets, Vol. 10, Iss. 6, 2010-01 ,pp. : 611-622

Bentham Science Publishers

Access to resources Recommend Favorite

Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice

By Colon Jimmie   Basha Md.   Madero-Visbal Rafael   Konduri Santhi   Baker Cheryl   Herrera Luis   Safe Stephen   Sheikh-Hamad David   Abudayyeh Ala   Alvarado Beatrice   Abdelrahim Maen  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 41-51

Springer Publishing Company

Access to resources Recommend Favorite

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

By Sonpavde Guru   Hutson Thomas E   Sternberg Cora N  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 2, 2008-02 ,pp. : 253-261

Informa Healthcare

Access to resources Recommend Favorite

Oncogenic Variant RON160 Expression in Breast Cancer and its Potential as a Therapeutic Target by Small Molecule Tyrosine Kinase Inhibitor

By  

Current Cancer Drug Targets, Vol. 13, Iss. 6, 2013-07 ,pp. : 686-697

Bentham Science Publishers

Access to resources Recommend Favorite

Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

By Kataoka Yu  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1352-1360

Springer Publishing Company

Access to resources Recommend Favorite